๐Ÿ””Stock Alerts via Telegram โ€” Free for All Users

VMD Stock Risk & Deep Value Analysis

Viemed Healthcare Inc

Healthcare โ€ข Medical Devices

DVR Score

9.0

out of 10

Hidden Gem

The Bottom Line on VMD

We analyzed Viemed Healthcare Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran VMD through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 14, 2026โ€ขRun Fresh Analysis โ†’

๐Ÿ“ˆVMD Performance Overview3yr weekly

๐Ÿ“Š

Unlock VMD Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

VMD Stock Risk Analysis

Overall Risk

Moderate

Financial Risk

Low

Market Risk

Medium

About Viemed Healthcare Inc (VMD)

Sector

Healthcare

Industry

Medical Devices

Market Cap Category

small

Market Cap

$250.56M

VMD Deep Value Analysis

Viemed Healthcare Inc. continues to demonstrate a compelling case for substantial growth, maintaining its strong previous score. The company's strategic positioning within the rapidly expanding tech-enabled home respiratory and chronic care market remains a key driver. Its scalable, integrated care model, combining advanced technology with specialized clinical expertise, offers a robust competitive advantage. Consistent execution, solid financial health, and a clear vision for capturing significant market share in a large, underpenetrated addressable market reinforce its 10x growth potential within 3-5 years. Favorable demographic and healthcare trends further support VMD's trajectory towards market leadership. While regulatory risks are inherent in healthcare, VMD's fundamental strengths and operational momentum are compelling.

VMD Red Flags & Warning Signs

Premium
  • โš 

    Adverse changes to Medicare/Medicaid reimbursement rates for home health services

  • โš 

    Key competitor product or service launch that gains significant traction

  • โš 

    Increased regulatory scrutiny or compliance challenges (e.g., Stark Law, Anti-Kickback Statute)

  • โš 

    Failure to meet or exceed revenue/EBITDA guidance in upcoming earnings reports

Unlock VMD Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

VMD Financial Health Metrics

Market Cap

$250.56M

P/E Ratio

19.00

VMD Competitive Moat Analysis

Premium

Moat Rating

Narrow

Moat Trend

Expanding

Moat Sources

3 Identified

Switching CostsIntangible Assets/IPCost Advantages

Viemed's moat is built on its integrated technology and specialized clinical services, creating significant switching costs for patients and referring physicians. As the company scales, its data-driven insights and operational efficiencies will further entrench its position, making it difficult for competitors to replicate the full patient journey experience without significant investment and clinical expertise.

VMD Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

VMD Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขQ4 2025 Earnings Report (expected early-March 2026, assuming positive performance)
  • โ€ขNew state or service line expansion announcements (Q1/Q2 2026)
  • โ€ขIncreased adoption rates for remote patient monitoring solutions

Medium-Term (6-18 months)

  • โ€ขStrategic partnerships with major health systems or insurers (H2 2026 - H1 2027)
  • โ€ขExpansion into adjacent chronic care verticals beyond respiratory (2027)
  • โ€ขFavorable shifts in Medicare Advantage or commercial insurance reimbursement for home-based care

Long-Term (18+ months)

  • โ€ขBecoming a dominant national platform for integrated home-based chronic care (2028-2030)
  • โ€ขPotential strategic M&A activity to consolidate the fragmented home healthcare market (2028+)
  • โ€ขBroader legislative support and funding for telehealth and home healthcare models

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

VMD Bull Case: What Could Go Right

  • โœ“

    Consistent double-digit revenue and Adjusted EBITDA growth rates

  • โœ“

    Expansion into new states or successful diversification into additional chronic care conditions

  • โœ“

    Positive commentary on reimbursement trends or new strategic partnerships

  • โœ“

    Evidence of increasing operating leverage and margin expansion

Bull Case Analysis

See what could go right with Premium

๐Ÿ””

Never miss a move on VMD

Create a free account to set price alerts and get notified on Telegram when VMD hits your targets.

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Viemed Healthcare Inc (VMD)?

As of March 14, 2026, Viemed Healthcare Inc has a DVR Score of 9.0 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Viemed Healthcare Inc?

Viemed Healthcare Inc's market capitalization is approximately $250.6M. The company operates in the Healthcare sector within the Medical Devices industry.

What ticker symbol does Viemed Healthcare Inc use?

VMD is the ticker symbol for Viemed Healthcare Inc. The company trades on the NCM.

What is the risk level for VMD stock?

Our analysis rates Viemed Healthcare Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of VMD?

Viemed Healthcare Inc currently has a price-to-earnings (P/E) ratio of 19.0. This is in line with broader market averages.

How often is the VMD DVR analysis updated?

Our AI-powered analysis of Viemed Healthcare Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 14, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.